Lymphopenia and clinical outcomes in patients with residual nodal disease after neoadjuvant chemotherapy for breast cancer.
Paulina M GutkinMargaret M KozakRie von EybenKathleen C HorstPublished in: Cancer causes & control : CCC (2020)
In patients with residual nodal disease after neoadjuvant chemotherapy, lymphopenia after breast cancer treatment was associated with overall survival. The relationship between lymphopenia and breast cancer outcomes warrants further investigation.